Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun;54(3):364-72.
doi: 10.1016/j.transci.2016.05.013. Epub 2016 May 12.

Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation

Hal E Broxmeyer  1
Affiliations
Review

Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation

Hal E Broxmeyer. Transfus Apher Sci. 2016 Jun.

Abstract

Clinical cord blood (CB) hematopoietic cell transplantation (HCT) has progressed well since the initial successful CB HCT that saved the life of a young boy with Fanconi anemia. The recipient is alive and well now 28 years out since that first transplant with CB cells from his HLA-matched sister. CB HCT has now been used to treat over 35,000 patients with various malignant and non-malignant disorders mainly using HLA-matched or partially HLA-disparate allogeneic CB cells. There are advantages and disadvantages to using CB for HCT compared to other sources of transplantable hematopoietic stem (HSC) and progenitor (HPC) cells. One disadvantage of the use of CB as a source of transplantable HSC and HPC is the limited number of these cells in a single CB collected, and slower time to neutrophil, platelet and immune cell recovery. This review describes current attempts to: increase the collection of HSC/HPC from CB, enhance the homing of the infused cells, ex-vivo expand numbers of collected HSC/HPC and increase production of the infused CB cells that reach the marrow. The ultimate goal is to manipulate efficiency and efficacy for safe and economical use of single unit CB HCT.

Keywords: Cord blood; Cord blood collection; Dipeptidylpeptidase 4; Hematopoietic stem and progenitor cells; Oxygen tension.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Broxmeyer HE, Farag SS, Rocha V. Cord blood hematopoietic cell transplantation. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR, editors. Thomas’ Hematopoietic Cell Transplantation. 5th. Chapter 39. Oxford, England: John Wiley & Sons, Ltd; 2016. pp. 437–455.
    1. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation – the first 25 years and beyond. Blood. 2013;122:491–498. - PMC - PubMed
    1. Shaheen M, Broxmeyer HE. The humoral regulation of hematopoiesis. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop H, Anastasi J, editors. Hematology: Basic Principles and Practice. Part III. 5th. Chapter 24. Philadelphia, PA: Elsevier Churchill Livingston; 2009. pp. 253–275.
    1. Broxmeyer HE, Srour E, Orschell C, Ingram DA, Cooper S, Plett PA, Mead LE, Yoder MC. Cord blood hematopoietic stem and progenitor cells. In: Lanza R, Gearhart J, Hogan B, Melton D, Pedersen R, Thomas ED, Thomson J, Wilmert I, editors. Essential Stem Cell Biology. Chapter 17. 2nd. San Diego, CA: Academic Press, Elsevier Science; 2009. pp. 151–156.
    1. Broxmeyer HE. Cord blood hematopoietic stem cell transplantation. In: StemBook, editor. The Stem Cell Research Community. StemBook; 2010. http://www.stembook.org, In Print, on-line.